metabolic syndrome; metabolism; hypoxia; V O2max; hypertrophy ALTHOUGH MAXIMAL OXYGEN UPTAKE (V O 2max ) is statistically linked with cardiovascular mortality (23, 36) , the mechanistic nature of this association is unknown and difficult to explore in humans. Specifically, it is well defined that the continuum of heart function is linearly related with the level of V O 2max (39) . Within the gene-environment interactions, inheritance may account for as much as 70% of the variation in aerobic capacity in human (7) . Hence, genetic predisposition and inborn aerobic capacity are likely to contribute toward cardiovascular disease and mortality.
Rats with different inborn running capacities have been artificially selected over generations to generate strains with genetically determined high or low intrinsic capacity (25) . The evolved strains of high capacity runners (HCR) and low capacity runners (LCR) have a 30% difference in V O 2max (17) . Selecting for low running capacity also resulted in accumulation of risk factors that predispose to cardiovascular disease. That is, LCR have features of the metabolic syndrome, whereas HCR show an athletic phenotype with markedly better cardiac and vascular function relative to LCR (17, 52) . These models were generated expressly for efficient and invasive evaluation of cardiometabolic disease that can lead to highly focused, mechanistic-based, studies in humans.
Here we performed whole genome microarray analysis to screen for differences in cardiac gene expression between LCR and HCR rats in sedentary and exercise-trained conditions. We hypothesized that genes differentially expressed between the sedentary LCR and HCR that regressed with aerobic capacity would include a set at least partly responsible for the differences in aerobic capacity between the strains. The cardiac gene set expressed in response to training was not different between the LCR and HCR. For the sedentary rats, 1,540 cardiac genes were differentially expressed for pathways including cardiac energy substrate, growth signaling, contractility, and cellular stress.
MATERIALS AND METHODS
Animals. We used rats artificially selected for high and low aerobic capacity, starting from the N: NIH stock obtained from the National Institutes of Health (NIH) (US). The model is described elsewhere (25, 52) . Briefly, the rats in each generation were tested for exercise capacity by treadmill running at 11 wk of age. The individuals with the highest and lowest running capacity were selected, and each group served as the mating population for the next generation. Female rats from generation 16 were used in this study. The study includes four groups: LCR trained (n ϭ 4), LCR sedentary (n ϭ 4), HCR trained (n ϭ 4), and HCR sedentary (n ϭ 4). Experimental protocols were approved by the respective Institutional Animal Research Ethics Councils.
Endurance training. We trained the rats with an aerobic interval training program that was previously described by Høydal et al. (17) . In brief, after 10 min of warm-up, rats ran uphill (25°) on a treadmill for 1.5 h, alternating between 8 min at an exercise intensity corresponding to 85-90% of V O2max and 2 min of active recovery at 50 -60%. Exercise was performed 5 days per week over 8 wk; controls were age-matched rats that remained sedentary. We measured V O2max every week in exercising rats to adjust speed to maintain the intended intensity throughout the experimental period. The V O2max test protocol consisted of 20 min warm-up at 50 -60% of V O2max, whereupon treadmill velocity was increased by 0.03 m/s every 2 min until VO 2 plateau despite increased workload. The apparatus and method have been previously described and validated (17) . The animals in the sedentary groups were treated similarly to the exercise Article published online before print. See web site for date of publication (http://physiolgenomics.physiology.org).
groups, except for exposure to exercise training and weekly V O2max tests.
Tissue collection. At ϳ7 mo of age and 48 h after the last exercise session all the animals were killed. One section of the left ventricle was formalin fixated for immunohistochemistry and morphological studies, whereas another section was snap-frozen in liquid nitrogen and stored at Ϫ80°C for later genetic screening and protein analysis.
Cardiomyocyte dimension measurements. Single cardiomyocytes from the left ventricle were dissociated by a previously described protocol (51) . In brief, the heart was removed immediately after animals were killed, kept for 1 min in ice-cold perfusion buffer, and connected to a standard Langendorff retrograde perfusion system for cell isolation. Cell length and midpoint width were measured in 50 morphologically intact myocytes from four sedentary HCR and four sedentary LCR.
Ribonuclease (RNA) isolation. Tissue samples (20 mg) were homogenized in 100 l TRIzol (Life Technologies, Gaithersburg, MD) using a Mixer Mill MM301 (Geneq, Montreal, Canada) at 20 -25 Hz. RNA clean-up was performed using RNA Mini kit (Qiagen, Germantown, MD). RNA isolation and clean-up were performed according to the manufacturer's instructions.
RNA integrity, purity, and quantity were assessed by Bioanalyzer (Agilent Technologies, Santa Clara, CA) and Nanodrop (NanoDrop Technologies, Baltimore, MD). The concentration of total RNA was measured by Nanodrop with ultraviolet spectrophotometry at 260/280 nm. RNA quality was assessed by electrophoresis on Bioanalyzer chips (Agilent Technologies). High-quality RNA was classified as a 260/280 ratio Ͼ1.8. Only samples with a 260/280 ratio between 1.8 and 2.2 and no signs of degradation were used for analysis.
Processing of Affymetrix data. Labeled cRNA was prepared and hybridized to the RAE 230 2.0 chip from Affymetrix GeneChip (Affymetrix, Santa Clara, CA) comprising 31,042 probe sets. On the Affymetrix GeneChip arrays, each gene was represented by a set of 11-20 probe pairs consisting of a perfect match (PM) and a mismatch probe. The statistical analysis is based on summary expression measures for each probe set.
Computing summary measures. The summary measure for each probe set is computed based on a linear statistical model for background-corrected, normalized, and log-transformed PM values for each probe pair by use of the robust multiarray average (RMA) method (21) . The PM values are normalized by the quantile normalization method (5); the arrays are normalized such that the empirical distribution of the expression measures is equal across arrays.
Statistical analysis for finding differentially expressed genes. For each gene (probe set), a linear regression model, including parameters representing the effect of aerobe capacity, is specified. Based on the estimated effects, tests for significant differential expression are performed by moderated t-tests (44) .
To account for multiple testing, we calculated adjusted P values controlling the false discovery rate (FDR), with the use of the Benjamini-Hochberg step-up procedure (4) . Consequently, selecting differentially expressed genes based on a threshold of 0.05 on the adjusted FDR P values means that the expected proportion of genes falsely classified as differential expressed should be Ͻ0.05.
All statistical analyses on the gene expression data are performed using the R language (R Development Core Team, 2004) and packages affy, affyPLM, and limma from the Bioconductor project (12) .
Database submission. The microarray data were prepared according to Minimum Information About Microarray Experiment (MIAME) recommendations and deposited in the Gene Expression Omnibus database (http://www.ncbi.nlm.nih.gov/geo/) with accession number GSE9445.
Functional clustering according to gene ontology annotations. To obtain information about gene functions, we used the eGOn web tool described by Beisvag et al. (3) . Lists of differentially expressed genes between HCR and LCR (P Ͻ 0.05) were submitted into eGOn, which automatically associates Gene Ontology (GO) terms from public databases to the submitted gene reporters. Annotations according to GO were obtained from the Norwegian Microarray Consortium annotation database (www.genetools.no), which was based on UniGene build no. 157 from November 2006.
We applied the master-target test from eGOn to assess the relative numbers of GO annotations linked to differentially expressed genes, compared with the relative numbers of the same GO annotations linked to all the genes on the microarray. We also applied the mutually exclusive target-target test to compare the genes that were significantly more expressed in HCR with the genes that were significantly more expressed in LCR.
The differentially expressed genes were also imported into the Ingenuity Pathway Analysis Application Tool to identifying gene networks that significantly describes the differences between HCR and LCR.
Validation of microarray results. Left ventricle protein levels of adenosine triphosphate (ATP) synthase (mitochondrial F1 complex), the major histocompatibility complex class I (MHC Cl. I), tubulin, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were mea- Exercise capacity and isolated left ventricular cell variables from low capacity runners (LCR) and high capacity runners (HCR), separated in groups of sedentary control (SED) and exercise-trained (TR). Before exercise, the LCR-SED and HCR-SED rats differed significantly (*P Ͻ 0.01) for all variables. LCR-TR had significantly improved function compared to LCR-SED ( †P Ͻ 0.01), and the HCR-TR had improved function compared to HCR-SED ( ‡P Ͻ 0.01). More details on the functional data are published in Høydal et al. (17) . sured to confirm that single genes and pathways were the same at protein level, as on gene level.
Homogenized left ventricular samples (n ϭ 4 per group) were loaded onto a 4 -12% NuPAGE Bis-Tris Gel (Invitrogen, Carlsbad, CA), separated by electrophoresis, and transferred to a Protran 85 nitrocellulose membrane (Whatman, Kent, UK). The membrane was incubated with ATP synthase (mitochondrial F1 complex) (Santa Cruz Biotechnology, Santa Cruz, CA), tubulin (Sigma-Aldrich, St. Louis, MO), and GAPDH (Santa Cruz Biotechnology) primary antibodies. Horseradish peroxidaseconjugate secondary antibodies and enhanced chemiluminescence (Amersham Biosciences, Piscataway, NJ) were used for protein detection. All protein levels were normalized to total actin (Sigma-Aldrich) and quantitated using ImageQuant software (Molecular Dynamics, Sunnyvale, CA).
The protein levels of MHC Cl. I (Abcam, Cambridge, UK) were analyzed on formalin-fixed, paraffin-embedded left ventricular sections (4 m) by a standard immunohistochemistry protocol. Results were visualized by Envision ϩ TM detection system (DakoCytomation, Glostrup, Denmark). The degree of positive-staining was determined by semiquantitative microscopy, arranging all the stained tissue specimens from the highest to the lowest degree of staining in two separate staining experiments.
Statistics for protein levels. Data are presented as means Ϯ SE. To analyze statistical difference within groups we applied two-tailed Student t-test using Prism software (GraphPad Software). P Ͻ 0.05 was considered statistically significant.
RESULTS
Physiological data. Previous studies of the same strains of animals reported that LCR were born with a higher cardiovas- Gene expression data. Of the 28,000 screened genes in the microarray analyses, a total of 1,540 genes were differentially expressed between the sedentary HCR and LCR (P Յ 0.05); 618 of the genes were more expressed in HCR vs. LCR, and 922 were more expressed in LCR vs. HCR. Only one gene was found differentially expressed by exercise training in this study. This gene (probe set: 1374916_at) was found upregulated by exercise in the LCR group but had unknown name and function. Differences between the four groups are illustrated in a heat map (Fig. 1) .
Gene clusters and cellular pathways. Biological processes, molecular functions, and cellular components describing the differences between HCR and LCR are listed in Table 2 . Molecular functions and biological processes significantly more represented in HCR vs. LCR are listed in Table 3 .
Ingenuity Pathway Analysis revealed a significant cardiotoxicity in LCR, whereas HCR were characterized by increased Ca 2ϩ signaling (Table 4) . The most differentially expressed genes. The genes with the greatest fold-change of increase in HCR compared with LCR are displayed in Table 5 , whereas the genes with the greatest fold-change of increase in LCR compared with HCR are displayed in Table 6 . These genes are also among the most significant genes in the study. Genes identified as "transcribed loci" or that were not in the UniGene database were not included in Tables 5 and 6 .
Verification of gene expression results on protein level. Left ventricle protein levels of ATP synthase (mitochondrial F1 complex) and MHC Cl. I were measured to confirm single genes that were found among the most-differentially expressed genes (Table 6 ). Both proteins were more expressed in LCR than HCR, as in line with the gene expression data (Figs. 2 and 3) .
Protein levels of tubulin and the microtubule binding protein, GAPDH were measured to support the results showing that microtubule-based processes were more pronounced in LCR than HCR (Table 3 ). Both proteins were more expressed in LCR than HCR, as in line with the gene expression data (Fig. 2) .
DISCUSSION
Genes differentially expressed between the sedentary HCR and LCR that also regress with aerobic capacity are considered to include a set of genes at least partly responsible for the differences in aerobic capacity between the strains. Because of the strong linkage between aerobic function and disease, this set of differentially expressed genes is also postulated to handling in response to exercise training (17) . Exercise training did in fact restore the inherited disadvantages of LCR in terms of V O 2max , cardiomyocyte contractility, and Ca 2ϩ handling (17) . Although previous studies in rats have reported significant changes in cardiac gene expression in response to training (20, 22, 34) , we only detected one gene in this study. Due to clear left ventricular alterations in response to exercise, the lack of significant findings at the mRNA level might be explained by strict statistical demands under-reporting differentially expressed genes. As in this study, several genes have high differential expression, so minor changes, although significantly in vivo, might not make the statistical cut-off.
Cardiac metabolism. The most prominent difference between sedentary HCR and LCR was the cardiac energy metabolism. HCR expressed higher amounts of genes involved in lipid metabolism, whereas LCR expressed higher amounts of HCR Ͼ LCR, the number of genes significantly more expressed in HCR than LCR that belong to a certain molecular function or biological process. HCR Ͻ LCR, the number of genes significantly more expressed in LCR than HCR that belong to a certain molecular function or biological process.
the genes involved in glucose metabolism and transport. By simply selecting for running capacity, we have created a difference in cardiac energy substrate utilization from the normal mitochondrial fatty acid ␤-oxidation (FAO) in HCR to carbohydrate metabolism in LCR. In a diseased heart the main energy substrate often switches from FAO to carbohydrate metabolism, with a downregulation of enzymes involved in FAO (38) . Initially, this improves the efficiency of the heart, since the amount of ATP produced per O 2 consumed is higher in glucose oxidation than FAO. However, as the condition progresses towards an uncompensated state, the capacity of utilizing glucose decreases (28) .
Running capacity is related to the ability to deliver and utilize oxygen (O 2 ) (49). It has previously been shown that LCR have impaired O 2 supply, extraction ratio, and tissue diffusion capacity, compared with HCR (15, 16) . In line with impaired O 2 availability in LCR, the biological process response to hypoxia was found to separate HCR from LCR. Since hypoxia reduces FAO (19) and increases glucose metabolism (27) , the lower tissue O 2 in LCR may explain the changes in cardiac energy metabolism. Reduced O 2 supply to peripheral tissue in LCR (15) are supported by the lower expression of genes associated with hemopoiesis, such as the hemoglobin ␤-chain complex. In our experimental situation, these genes were probably detected from remains of coagulated blood in the tissue samples.
Differences in metabolism may be linked to uncoupling protein 4 (UCP4). Uncoupling proteins are potential regulators of FAO, and high expression is associated with high resting metabolism, low fasting plasma glucose and insulin levels, and an increased glucose clearance rate (6, 8) . Different expression of cardiac UCP4 might be involved in determining cardiovascular risk, and might be a target for pharmacological interventions.
Energy, whether originating from glucose metabolism or FAO, is mainly generated in the respiratory chain. mRNA encoding two respiratory chain enzymes, ATP synthase (mitochondrial F1 complex) and nucleoside diphosphate kinase, was more abundant in LCR compared with HCR. This might be a compensatory mechanism to increase the energy production and has previously been reported in failing human hearts (31) .
Blood lipids. We have previously reported high levels of plasma triglycerides and free fatty acids in LCR (52) , which partly may be explained by low expression of cholesterollowering proteins as very low density lipoprotein receptor (VLDLr) and colony stimulating factor 1 (CSF1), as reported here and elsewhere (18, 37, 38, 53) . Administration of CSF1 has been tested as a potential therapy for hypercholesterolemia and atherosclerosis, and favorable results have been reported (50) . Low expression of CSF1 and VLDLr, in addition to a general lower FAO, might explain the accumulation of serum triglycerides and free fatty acids in LCR. Top toxicological functions cardiotoxicity -cardiac proliferation (P ϭ 0.036) hepatoxicity -hyperproliferation (P ϭ 0.027) Top pathways chemokine signaling (P Ͻ 0.00) protein ubiquitination pathway (P Ͻ 0.00) axonal guidance signaling (P Ͻ 0.00) riboflavin metabolism (P Ͻ 0.00) Ca 2ϩ signaling (P ϭ 0.00) estrogen receptor signaling (P Ͻ 0.00) Ca 2ϩ signaling and contractility. We have previously reported impaired contractility and Ca 2ϩ handling in LCR cardiomyocytes (17, 52) . One the mRNA level, Ca 2ϩ signaling was found to be significantly more pronounced in HCR than LCR, suggesting that impaired Ca 2ϩ signaling may be involved in the depressed contractility observed in LCR. In cardiac muscle, Ca 2ϩ signaling also play a central role in regulating gene expression, hypertrophy, and apoptosis (54) .
Both cholinergic receptor (nicotinic, alpha polypeptide 1) and inward rectifying potassium (K ϩ ) channel (subfamily J, member number 3) were less expressed in LCR than HCR. These ion channels regulate the heart rate and contractility. Less inward K ϩ channels in LCR will potentially lower the myocyte membrane potential, hence making the myocytes from LCR more susceptible to delayed after-depolarization and ventricular tachyarrhythmia, which was recently reported in this animal model (30) . Reduced density of inward rectifying K ϩ channels and a lower resting membrane potential have been reported in failing human hearts (26) .
LCR also expressed less CD38 than HCR. CD38 is responsible for most of the synthesis of cyclic-ADP-ribose in the myocardium, which in turn controls the Ca 2ϩ homeostasis in cardiac myocytes. Cyclic-ADP-ribose enhances the sensitivity of Ca 2ϩ -induced Ca 2ϩ release from the sarcoplasmic reticulum, and thus the contraction (46) . This coincides with the previously reported lower Ca 2ϩ transient and contractility in LCR myocytes (17, 52) .
Physiological versus pathological growth signaling. The cardiomyocyte shape represents an interesting phenotypic characterization of cardiac hypertrophy. Cardiomyocyte volume correlates with cardiac mass in a variety of conditions, including pressure and volume overload, hyperthyroidism, and postmyocardial infarction (14, 24, 55) . In physiological conditions, the width/length ratio is tightly regulated and remains unchanged in normal body growth (41) ; however, this may change under certain conditions. In this study, we found a large cardiomyocyte width in LCR. An increase in width is most often associated with pressure overload (13) . This is in consensus with our previous findings of significantly elevated mean blood pressure in LCR compared with HCR (52) .
Increased cardiomyocyte size in LCR was consistent with the gene expression data reporting cardiac proliferation as the most significant pathological function detected in LCR. The presence of hypertrophic signaling in LCR was further emphasized by the high expression of glycolytic enzymes, as glucose is a more efficient substrate for ATP production than free fatty acids (48) . Pathological hypertrophy is also linked to upregulation of genes associated with embryonic growth, as mRNAs encoding s-adenosylmethionine decarboxylase, transducer of ErbB-2 (1), fibroblast growth factor 1, transforming growth factor, beta 3, and TBP-interacting protein 120B (2) were significantly more abundant in LCR than in HCR. In addition, LCR expressed more of the voltage-dependent L-type Ca 2ϩ channel ␣1C pore subunit than HCR, whose upregulation has been associated with maladaptive growth and heart failure in mice (35) . Microtubule (MT)-based processes were more pronounced in LCR than HCR. This can be related to our findings of elevated blood pressure (52) and pathological cardiac growth in LCR, since increased MT density and increased level of MT binding proteins are associated with pressure overload cardiac hypertrophy (9, 40, 45) . MTs are also involved in hypoxic signaling, which was found to be different in HCR and LCR. MTs have been suggested to regulate translation of the hypoxia-inducible factor 1␣, but the mechanism is not yet elucidated (11) . Even so, drugs destroying MTs are used to disrupt hypoxic signaling in cancer (32) . To support the importance of MT-based processes in LCR, we analyzed the protein levels of tubulin and the MT-binding protein, GAPDH and found higher levels of both proteins in LCR compared with HCR.
In contrast to LCR, HCR seem to have a healthier cardiac growth signaling pattern, based upon a higher expression of genes associated with tissue development and remodeling. HCR expressed more collagen type XVIII ␣1 and the collagenbreakdown protein matrix metalloproteinase 2 than LCR. This suggests a higher tissue turnover rate in HCR than LCR, with continuous breakdown and construction of the connective tissue in the heart. Interestingly, angiogenesis was significantly more pronounced in HCR compared with LCR. Angiogenesis is normally enhanced during the acute phase of adaptive cardiac growth, but as the heart enters the chronic phase of pathological remodeling, angiogenesis is normally impaired. In fact, disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure (42) . This suggests that the cardiac pathological growth in LCR might be past the acute phase and is now accompanied by impaired angiogenesis. The pathological cardiac hypertrophy with reduced contractility as in our animal model (17) has also previously been accompanied by impaired coronary angiogenesis (42) .
Cellular stress. Clusters of differentially expressed genes associated with DNA damage and hypoxia suggest a cardiac stress response in LCR. This is further emphasized by the 2.5 times higher expression of the mRNA decapping enzyme in LCR. Increased expression of the Saccharomyces cerevisiae homolog is observed under osmotic, oxidative, heat, and metabolic stress conditions (33) . Since decapping activity is likely to be conserved in other species (47) , oxidative and metabolic stress conditions might occur in LCR hearts. In addition, LCR expressed high amounts of DNA damage-inducible transcript 4, which is particularly upregulated following hypoxia (10, 43) .
LCR expressed 50 times more of the inflammatory regulator RT1 class 1 locus A1 than HCR, which also was confirmed at the protein level. Upregulation of the human analog, MHC Cl.I has been found in the myocardium of inflammatory cardiomyopathy patients (29) . This suggests a prevailing inflammatory process in the myocardium of LCR rats.
Study limitations. This study could not determine whether the identified differential gene expression patterns represent the cause or the consequence of the inborn differences in aerobic capacity. Further follow-up studies with modification of particular genes are needed for this purpose. Since the expression of mRNA does not necessarily reflect the expression of the protein, we chose to validate some of our microarray results on protein levels rather than the gene level. By this approach, pathogenic mechanisms of disease that involve protein modifications are accounted for.
Conclusion
This study has demonstrated that differences in inborn aerobic capacity are associated with differences in gene expression patterns in the heart. It has also generated novel hypotheses on the association between inborn aerobic capacity and the risk for developing cardiovascular disease.
The cardiac gene expression pattern of inborn low aerobic capacity involves activation of survival mechanisms to meet the body's demands. First, the low aerobic capacity is associated with a metabolic switch from oxidation of fatty acids to glucose, thus improving the energy efficiency of the heart, e.g., in early stages of heart failure. Second, upregulation of embryonic growth factors and increased cardiomyocyte size suggest a growth pattern with elements of pathological signaling. Hypoxic conditions might be the common source for all these observations, triggering hypoxia-induced alterations of transcription toward compensatory mechanisms for an insufficient heart.
